Weight management and cardiovascular risk reduction: The role of Semaglutide 2.4mg
Description
In this Product Explainer, Dr. Robert Hungerford, GP with a special interest in ASCVD, heart failure and diabetes, explains the role of Semaglutide 2.4mg in weight management and cardiovascular risk reduction in secondary prevention (7 mins).
NEXT LIVE Webcast
:
Days
:
Hours
:
Minutes
Seconds
Prof Andrew Sindone
An Update on Heart Failure in Primary Care
Dr Gabby Mahoney
Allergen Introduction – Practical Tips for GPs
Prof Kim Delbaere
Falls Prevention – A Practical, Evidence-Based Update on What Really Works
Dr Terri Foran
Vulvovaginal Health – From Childhood to Menopause
Join us for the next free webcast for GPs and healthcare professionals
High quality lectures delivered by leading independent experts
